Pharsight

Drugs that contain Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate

1. Mydayis patents expiration

MYDAYIS Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6913768 TAKEDA PHARMS USA Sustained release delivery of amphetamine salts
May, 2023

(9 months ago)

US9173857 TAKEDA PHARMS USA Controlled dose drug delivery system
May, 2026

(2 years from now)

US8846100 TAKEDA PHARMS USA Controlled dose drug delivery system
Aug, 2029

(5 years from now)

Drug Exclusivity Drug Exclusivity Expiration
Pediatric Exclusivity (PED) Mar 13, 2023

Market Authorisation Date: 20 June, 2017

Treatment: Treatment of attention deficit hyperactivity disorder

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

How can I launch a generic of MYDAYIS before it's drug patent expiration?
More Information on Dosage

MYDAYIS family patents

Family Patents